Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Cardiac Biomarkers Market From 2025 To 2029?

The market size for cardiac biomarkers has seen a swift expansion in the last couple of years. The market value is estimated to increase from $18.99 billion in 2024 to $21.19 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.6%. The past growth in this market can be linked to factors like heightened healthcare spending, approvals and regulatory backing from the FDA, the aging demographic, public awareness initiatives, the utilization of high sensitivity troponin tests, as well as the rise in cardiovascular diseases.

There is an anticipation for a swift expansion of the cardiac biomarkers market in the coming years. The market is projected to reach a valuation of $36.55 billion in 2029, growing at a compound annual growth rate (CAGR) of 14.6%. The escalation during the forecast period can be linked to an increasing prevalence of chronic diseases, greater focus on early detection of illnesses, the growth of the elderly population, advancements in emerging markets, and concentration on biomarker panels. The forecast period will observe significant trends such as healthcare models centred on patients, applications of artificial intelligence and machine learning, the merging of digital health, technological breakthroughs in biomarker discovery, multi-marker panels, and the application of liquid biopsies in cardiovascular medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp

What Are the Core Growth Drivers Propelling the Cardiac Biomarkers Market Forward?

The cardiac biomarker market’s growth is anticipated to be fueled by the increasing rate of cardiovascular disorders. Cardiovascular diseases, which include ailments affecting the heart and blood vessels like stroke, heart failure, and coronary artery disease, increase the release of cardiac biomarkers into the bloodstream. These biomarkers’ levels can be measured with laboratory tests and offer vital diagnostic and prognostic insights regarding various heart conditions such as arrhythmias, heart failure, and myocardial infarction. For example, data from the British Heart Foundation, an esteemed cardiovascular research charity in the UK, revealed that around 7.6 million people, including nearly 4 million men and 3.6 million women, were living with heart and circulatory diseases in the UK as of September 2024. These conditions are behind around 27% of all UK deaths, resulting in over 170,000 deaths per year, or approximately 480 daily deaths – equating to one death every three minutes. Consequently, the upward trend of cardiovascular diseases is bolstering the expansion of the cardiac biomarker market.

What Segment Types Define the Cardiac Biomarkers Market Structure?

The cardiac biomarkersmarket covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications

4) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels

2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels

3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels

5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels

6) By Other Biomarker Types: Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP), Other Emerging Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cardiac Biomarkers Market?

North America was the largest region in the cardiac biomarkers market in 2024. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theCardiac Biomarkers Industry Evolution?

Innovative progression is a notable trend that is becoming more prominent in the cardiac biomarker market. Companies in this field are integrating new technologies to maintain their market position. For example, in October 2023, Mindray, a medical device company based in China, released new high-sensitivity cardiac biomarkers troponin I (hs-cTnI) and NT-proBNP. These are designed to improve diagnosis and managing cardiovascular diseases (CVDs). The hs-cTnI biomarker is crucial in spotting myocardial injury as it demonstrates an impressive detection rate and minimal imprecision. This makes it highly useful for early screening and risk evaluation, particularly in cases like Acute Coronary Syndrome (ACS). Conversely, NT-proBNP is a commonly recognized marker for heart failure that supports its detection and handling, displaying high precision and minimal disturbance from commonly used heart drugs. Collectively, these biomarkers greatly enhance clinical decision-making in critical cardiovascular care scenarios.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

What Is the Definition of the Cardiac Biomarkers Market?

Cardiac biomarkers are chemicals released by heart into the blood when it is injured or under stress. It used for the detection and measurement of various cardiac vascular diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10234

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model